CompletedPhase 4

Escitalopram in Schizophrenia in OCD- Open Label Study

Israel15 participantsStarted 2006-07

Plain-language summary

SSRI's has been demonstrated to be partially effective in schizophrenia and OCD. We therefore suggest that Escitalopram up to 20 mg /d in those patients could be effective in reducing obsessive compulsive symptomatology

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients who suffer from schizophrenia and OCD Exclusion Criteria: * Substance abuse, * Serious medical condintions, * Being on SSRI treatment

Trial details

NCT IDNCT00456937

SponsorBeerYaakov Mental Health Center

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2008-09

View on ClinicalTrials.gov More Schizophrenia trials